Exposure-Response to SC Ustekinumab In Moderate-Severe Crohn's Disease: Results From the IM-UNITI Maintenance Study

被引：1
|
作者：
Adedokun, Omoniyi J. [1 ]
Xu, Zhenhua [1 ]
Gasink, Christopher [2 ]
Jacobstein, Douglas [1 ]
Szapary, Philippe [1 ]
Johanns, Jewel [1 ]
Gao, Long Long [2 ]
Davis, Hugh M. [1 ]
Hanauer, Stephen [3 ]
Feagan, Brian G. [4 ]
Ghosh, Subrata [5 ]
Sandborn, William J. [6 ]
机构：
[1] Janssen Res & Dev LLC, Spring House, PA USA
[2] Janssen Sci Affairs LLC, Horsham, PA USA
[3] Northwestern Univ, Feinberg Sch Med, Evanston, IL USA
[4] Western Univ, Robarts Res Inst, London, ON, Canada
[5] Inst Translat Med, Birmingham, W Midlands, England
[6] Univ Calif, La Jolla, CA USA
来源：
AMERICAN JOURNAL OF GASTROENTEROLOGY | 2017年 / 112卷
关键词：
D O I：
10.14309/00000434-201710001-00660
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
660
引用
收藏
页码：S365 / S365
页数：1
相关论文
共 50 条
  • [1] Exposure-Response to SC Ustekinumab in Moderate-Severe Crohn's Disease: Results From the IM-UNITI Maintenance Study
    Omoniyi, Adedokun
    Xu Zhenhua
    Christopher, Gasink
    Douglas, Jacobstein
    Philippe, Szapary
    Jewel, Johanns
    Long-Long, Gao
    Hugh, Davis
    Stephen, Hanauer
    Brian, Feagan
    Subrata, Ghosh
    William, Sandborn
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2018, 113 : S2 - S2
  • [2] EFFICACY & SAFETY OF DOSE ADJUSTMENT & DELAYED RESPONSE TO USTEKINUMAB IN MODERATE-SEVERE CROHN'S DISEASE PATIENTS: RESULTS FROM IM-UNITI MAINTENANCE STUDY
    Sands, B.
    Gasink, C.
    Jacobstein, D.
    Gao, L.
    Johanns, J.
    Szapary, P.
    Colombel, J.
    Targan, S.
    Ghosh, S.
    Sandborn, W.
    GUT, 2017, 66 : A23 - A23
  • [3] Pharmacokinetics and Exposure-Response Relationships of Ustekinumab during IV Induction and SC Maintenance Treatment of Patients with Crohn's Disease with Ustekinumab: Results from the UNITI-1, UNITI-2, and IM-UNITI Studies
    Adedokun, Omoniyi J.
    Xu, Zhenhua
    Gasink, Christopher
    Szapary, Philippe
    Johanns, Jewel
    Gao, Long-Long
    Davis, Hugh M.
    Hanauer, Stephen B.
    Feagan, Brian G.
    Sandborn, William
    GASTROENTEROLOGY, 2016, 150 (04) : S408 - S408
  • [4] Efficacy and Safety of Dose Adjustment and Delayed Response to Ustekinumab in Moderate - Severe Crohn's Disease Patients: Results from the IM-UNITI Maintenance Study
    Sands, Bruce
    Gasink, Chris
    Jacobstein, Doug
    Gao, Long Long
    Johanns, Jewel
    Szapary, Philippe
    Colombel, Jean-Frederic
    Targan, Stephan
    Ghosh, Subrata
    Sandborn, William J.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S302 - S303
  • [5] IMMUNOGENICITY OF USTEKINUMAB IN PATIENTS WITH CROHN'S DISEASE: RESULTS FROM THE IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Nussbaum, Jeannette
    Oortwijn, Alessandra
    Gasink, Christopher
    Jacobstein, Douglas
    Gao, Long-Long
    Adedokun, Omoniyi J.
    de Villiers, Willem J.
    Ghosh, Subrata
    GASTROENTEROLOGY, 2019, 156 (06) : S1097 - S1097
  • [6] Efficacy of ustekinumab in Crohn's disease at maintenance Week 56: IM-UNITI study
    Sandborn, W. J.
    Sands, B.
    Colombel, J. -F.
    Gasink, C.
    Patel, R.
    Jacobstein, D.
    Gao, L. -L.
    Ghosh, S.
    Targan, S.
    De Villiers, W.
    Hanauer, S. B.
    Rutgeerts, P.
    Feagan, B.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S274 - S274
  • [7] Efficacy, Safety and Timing of Dose Adjustment of Subcutaneous Ustekinumab Maintenance in Moderate -Severe Crohn's Disease Patients in IM-UNITI
    Bruce, Sands
    Christopher, Gasink
    Douglas, Jacobstein
    Gao Long-Long
    Jewel, Johanns
    Philippe, Szapary
    Jean-Frederic, Colombel
    Stephan, Targan
    Subrata, Ghosh
    William, Sandborn
    INFLAMMATORY BOWEL DISEASES, 2017, 23 : S9 - S9
  • [8] EFFICACY OF USTEKINUMAB IN CROHN'S DISEASE AT MAINTENENCE WEEK 56: IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Gasink, Christopher
    Patel, Rishit
    Jacobstein, Douglas
    Gao, Long-long
    Ghosh, Subrata
    Targan, Stephan
    De Villiers, Willem
    Hanauer, Stephen B.
    Rutgeerts, Paul
    Feagan, Brian G.
    GASTROENTEROLOGY, 2019, 156 (03) : S23 - S24
  • [9] A PH3 RANDOMISED, MULTICENTER, DOUBLE-BLIND, PLACEBO (PBO)-CONTROLLED STUDY OF USTEKINUMAB (UST) MAINTENANCE THERAPY IN MODERATE-SEVERE CROHN'S DISEASE (CD) PTS: RESULTS FROM IM-UNITI
    Sandborn, W. J.
    Feagan, B. G.
    Gasink, C.
    Jacobstein, D.
    Gao, L-L
    Johanns, J.
    Sands, B.
    Hanauer, S.
    Targan, S.
    Ghosh, S.
    de Villiers, W.
    Colombel, J-F
    Lee, S. D.
    Dieleman, L.
    Katz, S.
    Rutgeerts, P.
    GUT, 2016, 65 : A32 - A34
  • [10] EFFICACY OF USTEKINUMAB IN CROHN'S DISEASE AT MAINTENENCE WEEK 56: IM-UNITI STUDY
    Sandborn, William J.
    Sands, Bruce E.
    Colombel, Jean-Frederic
    Gasink, Christopher
    Patel, Rishit
    Jacobstein, Douglas
    Gao, Long-long
    Ghosh, Subrata
    Targan, Stephan
    De Villiers, Willem
    Hanauer, Stephen B.
    Rutgeerts, Paul
    Feagan, Brian G.
    INFLAMMATORY BOWEL DISEASES, 2019, 25 : S16 - S17
12345